About Admin

This author has not yet filled in any details.
So far Admin has created 97 blog entries.

U.S. ARMY CONTRACTING COMMAND AWARDS OLOGY BIOSERVICES CONTRACT TO RESERVE PRODUCTION CAPACITY IN SUPPORT OF OPERATION WARP SPEED

2020-08-26T08:11:25-04:00August 26th, 2020|

Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract by the U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland. The contract ceiling value is $106.3 million, of which $53.1 million was obligated at the time of award.

Ology Bioservices Wins Three Department of Defense Awards Totaling More Than $16 Million

2020-07-08T12:14:29-04:00July 8th, 2020|

ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of more than $16 million.

Department of Defense Awards Ology Bioservices Contract to Advance Anti-Botulism Neurotoxin Monoclonal Antibodies

2020-06-26T12:19:25-04:00June 25th, 2020|

ALACHUA, Fla. – June 25, 2020 – Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract to advance development of a cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD) through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The contract ceiling value is $42.6 million.

Just – Evotec Biologics to Collaborate with Ology Bioservices on Antibodies Against Coronavirus

2020-04-30T13:52:05-04:00April 30th, 2020|

Ology and Just - Evotech Collaborate to Develop Antibodies Against Coronavirus Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention of infection with Sars-CoV-2 Just – Evotec Biologics to supply antibody screening and analytical characterization of anti-covid-19 antibodies

Government Contracts for Biodefense

2020-04-02T15:12:10-04:00February 10th, 2020|

Government Contracts For Biodefense: The Benefits and Risks. Robert V. House, PhD, FATS, Senior Vice President of Government Contracts at Ology Bioservices shares his thoughts on the benefits of Government Contracting in an article recently published in the Washington Business Journal. Read it here

Go to Top